fbpx

World Pharma News

18

Mar2020
MSD has revealed new topline efficacy results from two ongoing pivotal Phase III trials, evaluating gefapixant (MK-7264) in ... Read More

18

Mar2020
Biotech giant Regeneron said it aims to have doses of a potential drug for COVID-19 ready to start ... Read More

18

Mar2020
Geneva, 16 March 2020 – Bristol-Myers Squibb (BMS) has announced that the marketing authorisations for Daklinza® (daclatasvir) will ... Read More

17

Mar2020
Following government issued advice to avoid all non-essential travel and contact in the UK, various pharmaceutical companies are ... Read More
Share this: